Inventor · disambiguated record
Michael Naso
Also filed as: NASO MICHAEL · NASO MICHAEL FRANCIS · NASO MICHAEL S
29 granted patents·21 pending applications·178 citations·filing 1987–2024
96Inventor score
Files withCENTURY THERAPEUTICS INC15JANSSEN BIOTECH INC14CENTOCOR INC4NASO MICHAEL4CENTOCOR ORTHO BIOTECH INC2
Top patents by PatentIndex Score
50 records- 0195US10786568B2AAV mediated influenza vaccinesUNIV PENNSYLVANIA·Filed 2018·Granted Sep 29, 2020·16 cites·18 claims
- 0292US9090694B2ST2L antibody antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Jul 28, 2015·19 cites·4 claims
- 0391US8975040B2Methods and vectors for generating asialylated immunoglobulinsJANSSEN BIOTECH INC·Filed 2013·Granted Mar 10, 2015·18 cites·6 claims
- 0490US9212227B2ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditionsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 15, 2015·13 cites·15 claims
- 0590US8519107B2IL-17A antibodiesALMAGRO JUAN CARLOS·Filed 2010·Granted Aug 27, 2013·24 cites·16 claims
- 0688US7605235B2Anti-tissue factor antibodies and compositionsCENTOCOR INC·Filed 2004·Granted Oct 20, 2009·36 cites·9 claims
- 0787US8540992B2Methods and vectors for generating asialylated immunoglobulinsNASO MICHAEL·Filed 2007·Granted Sep 24, 2013·11 cites·3 claims
- 0885US7427471B2Modified “S” antibodiesCENTOCOR INC·Filed 2003·Granted Sep 23, 2008·12 cites·13 claims
- 0984US9951137B2ST2L antagonists and methods of useJANSSEN BIOTECH INC·Filed 2015·Granted Apr 24, 2018·4 cites·6 claims
- 1081US7879978B2Macaca fascicularis ST2LCENTOCOR ORTHO BIOTECH INC·Filed 2009·Granted Feb 1, 2011·5 cites·5 claims
- 1179US11096998B2Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereofJANSSEN BIOTECH INC·Filed 2017·Granted Aug 24, 2021·1 cites·2 claims
- 1278US11161897B2Antigen binding regions against fibronectin type III domains and methods of using the sameJANSSEN BIOTECH INC·Filed 2018·Granted Nov 2, 2021·1 cites·1 claims
- 1376US10450377B2ST2L antagonists and methods of useJANSSEN BIOTECH INC·Filed 2018·Granted Oct 22, 2019·1 cites·18 claims
- 1476US9073996B2Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)UNIV NORTH CAROLINA·Filed 2013·Granted Jul 7, 2015·2 cites·5 claims
- 1572US9708410B2Anti-tissue factor antibodies and compositionsJANSSEN BIOTECH INC·Filed 2012·Granted Jul 18, 2017·2 cites·14 claims
- 1672US2024216429A1Chimeric antigen receptor system with adaptable receptor specificityCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1770US12269870B2Antigen binding regions against fibronectin type III domains and methods of using the sameJANSSEN BIOTECH INC·Filed 2021·Granted Apr 8, 2025·0 cites·4 claims
- 1870US8309688B2Monkey homolog of human oncostatin M and methods of use thereofCOTTY ADAM·Filed 2009·Granted Nov 13, 2012·1 cites·6 claims
- 1968US11883432B2Chimeric antigen receptor system with adaptable receptor specificityCENTURY THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·0 cites·13 claims
- 2068US2025059286A1Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2167US12269888B2Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·4 claims
- 2264US7479479B2CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and usesCENTOCOR INC·Filed 2007·Granted Jan 20, 2009·0 cites·10 claims
- 2363US2025360210A1Immunoeffector cells derived from induced pluripotent stem cells genetically engineered with membrane bound il12 and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2463US2025066728A1Compositions and Methods for Generating Gamma-Delta T Cells from Induced Pluripotent Stem CellsCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2562US2025090582A1Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2661US2022031822A1Chimeric antigen receptors comprising bcma-specific fibronectin type iii domains and uses thereofJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 2760US7931905B2Cynomolgus gp80 receptor and uses thereofCENTOCOR ORTHO BIOTECH INC·Filed 2009·Granted Apr 26, 2011·0 cites·9 claims
- 2859US2020332255A1Immortalized car-t cells genetically modified to eliminate t-cell receptor and beta 2-microglobulin expressionJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 2959US2025345425A1Cells engineered with an hla-e and hla-g transgeneCENTURY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3059US2019175651A1Immortalized car-t cells genetically modified to elminate t-cell receptor and beta 2-microglobulin expressionJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 3158US11661459B2Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2021·Granted May 30, 2023·0 cites·11 claims
- 3258US8293882B2Anti-tissue factor antibodies and compositionsANDERSON G MARK·Filed 2009·Granted Oct 23, 2012·0 cites·6 claims
- 3358US7326687B2CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and usesCENTOCOR INC·Filed 2004·Granted Feb 5, 2008·1 cites·9 claims
- 3458US2020390888A1Novel aav mediated influenza vaccinesUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 3554US2009137783A1CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and UsesSONG XIAO-YU R·Filed 2009·Application pending·0 cites
- 3654US2022333073A1Compositions and Methods for Generating Gamma-Delta T Cells from Induced Pluripotent Stem CellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3753US9587024B2Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)UNIV NORTH CAROLINA CHAPEL HILL·Filed 2015·Granted Mar 7, 2017·0 cites·35 claims
- 3853US2022332782A1Combined Artificial Cell Death/Reporter System Polypeptide for Chimeric Antigen Receptor Cell and Uses ThereofCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3953US2022331361A1Gene transfer vectors and methods of engineering cellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4052US2018016340A1Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1 (IGF-1)UNIV NORTH CAROLINA CHAPEL HILL·Filed 2017·Application pending·0 cites
- 4151US2022333074A1Compositions and Methods for Generating Alpha-Beta T Cells from Induced Pluripotent Stem CellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4247US9012602B2Macaca fascicularis CCL17NASO MICHAEL·Filed 2011·Granted Apr 21, 2015·0 cites·2 claims
- 4346US2022184123A1Genetically Engineered Cells and Uses ThereofCENTURY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4446US2022195396A1Genetically Engineered Cells and Uses ThereofCENTURY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4545US2008044420A1Anti-IL-13 antibodies, compositions, methods and usesHEAVNER GEORGE A·Filed 2006·Application pending·0 cites
- 4644US2015291946A1Methods and Vectors for Generating Asialylated ImmunoglobulinsJANSSEN BIOTECH INC·Filed 2015·Application pending·0 cites
- 4743US8338171B2Baboon homolog of human CD147SWENCKI-UNDERWOOD BETHANY·Filed 2010·Granted Dec 25, 2012·0 cites·5 claims
- 4842US4798352AFilm reel having film-threadable film-retaining coreNASO MICHAEL·Filed 1987·Granted Jan 17, 1989·5 cites·23 claims
- 4940US2016194405A1Anti-tissue factor antibodies and compositionsJANSSEN BIOTECH INC·Filed 2016·Application pending·0 cites
- 5037US4926339AComputer automated microfilm jacket feed and printer deviceNASO MICHAEL·Filed 1989·Granted May 15, 1990·6 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Michael Naso files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →